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Abstract:  Cigarette  use  is  a  known  risk  factor  for  the  development  of  coronary  artery 
disease (CAD) as it adversely affects HDL cholesterol levels and promotes thrombogenesis. 
Smoking may also be associated with behavioral characteristics that potentiate the risk of 
CAD. A lack of cholesterol knowledge would indicate an aversion to a prevention-oriented 
lifestyle.  Thus,  our  goal  was  to  determine  the  association  between  tobacco  use  and 
knowledge of self-reported cholesterol among male physicians. Using the 1982 and follow-
up questionnaires from the physician health study, we report the changes in the frequencies 
of awareness of self-reported total cholesterol and cardiovascular risk factors among the 
22,067 participants. We classified physicians as being aware of their cholesterol if they 
reported a cholesterol level and unaware if the question was left unanswered. In 1997, 207 
physicians were excluded, as the recorded cholesterol was not interpretable, leaving 21,860 
for our follow up analyses. Using unadjusted logistic models, we determined the odds ratios 
(OR) and 95% confidence intervals (CI) of not reporting a cholesterol level in either 1982 or 
1997  for  each  specified  risk  factor.  We  then  evaluated  whether  the  lack  of  cholesterol 
awareness at both time points was associated with the use of tobacco throughout the study. 
After 14-years of follow up, cholesterol awareness increased from 35.9 to 58.6 percent. 
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During this period, the frequency of hypertension and hyperlipidemia treatment increased 
(13.5 to 40.5% and 0.57% to 19.6% respectively), as did the diagnosis of diabetes (2.40 to 
7.79%). Behavioral characteristics such as a sedentary lifestyle and obesity also increased 
(27.8 to 42% and 43.5 to 53.5%, respectively), however the proportion of current smokers 
deceased  from  11.1  to  4.05%.  The  percentages  of  individuals  being  unaware  of  their 
cholesterol  decreased  in  all  risk  factor  groups.  However,  individuals  were  likely  to  be 
unaware of their cholesterol at both time points if they were current smokers (1982 OR 1.44, 
CI 1.4-1.7; 1997 OR 1.71, CI 1.48-1.97), past smokers (1982 OR 1.12, CI 1.05-1.18; 1997 
OR 1.13, CI 1.06-1.20), overweight (BMI 25 kg/m2) or sedentary. In addition, physicians 
who never quit smoking were likely to be unaware of their cholesterol throughout the study 
(OR 1.42, CI 1.21-1.67). Cholesterol awareness in general and among those with CAD risk 
factors improved after 14-years of follow-up. However, the likelihood of being unaware was 
greater  among  smokers  at  both  time  points.  Therefore,  smokers  do  not  appear  to  take 
advantage of other preventive strategies that would minimize their risk of developing CAD.  
Keywords: Disease prevention; cholesterol; lifestyle behavior; tobacco smoking. 
 
 
1. Introduction  
 
Cardiovascular  disease  is  a  significant  cause  of  morbidity  and  mortality  in  the  United  States. 
Smoking increases the risk for cardiovascular disease by decreasing levels of high-density lipoprotein 
cholesterol  and  promoting  thrombogenesis  [1,2].  In  addition,  patients  who  smoke  may  possess 
psychological traits such as hostility more frequently than non-smokers [3]. These traits have also been 
found to increase the risk of cardiovascular disease. 
Because smokers are at higher risk for cardiovascular disease, smokers could potentially benefit 
from  adoption  of  a  prevention-oriented  lifestyle.  Characteristics  of  a  prevention-oriented  lifestyle 
would include identifying risk factors for chronic medical disease such as cardiovascular disease and 
adopting risk reduction strategies [4]. Cholesterol is a known risk factor for cardiovascular disease and 
national guidelines recommend routine screening for hypercholesterolemia. Patients who are unaware 
of their cholesterol level are less likely to have elevated cholesterol treated and therefore less likely to 
reduce their cardiovascular risk. Little is known about the frequency of smokers to adopt a prevention-
oriented lifestyle. Therefore, we examined the frequency of cholesterol unawareness, as a surrogate for 
failure to adopt a prevention-oriented lifestyle, among physicians in the Physicians Health Study. 
 
2. Methods  
 
Our study population consisted of physicians who participated in the physicians’ health study (PHS) 
I and II. The PHS I was a randomized trial of aspirin and beta-carotene in the primary prevention of 
cardiovascular disease and cancer and consisted of 22,067 male physicians aged ≥ 40 years [5]. The 
PHS  II  is  a  randomized  trial  of  beta-carotene,  vitamin  E,  vitamin  C,  and  a  multivitamin  in  the 
prevention of cardiovascular disease, cancer, and eye disease and consisted of male physicians aged ≥ Int. J. Environ. Res. Public Health 2009, 6               
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50 years [6]. In both PHS I and PHS II, physicians were asked to provide self-reported cholesterol 
levels on the baseline questionnaire. Since many physicians that participated in PHS I also continued 
in PHS II we were able to capture follow up data on most of the participants with 14 years of time 
between  the  two  questionnaires.  Using  the  baseline  and  follow-up  (PHS  1  follow  up  or  PHS  II 
baseline) questionnaires, we report the changes in the frequencies of awareness of self-reported total 
cholesterol and cardiovascular risk factors among the 22,067 participants. Physicians were classified as 
being aware of their cholesterol if they reported a cholesterol level and unaware if the question was 
returned  blank.  Physicians  were  excluded  from  the  analysis  if  their  answer  to  the  question  was 
uninterruptable. 207 physicians were excluded from follow up, as the recorded cholesterol was not 
interpretable, leaving 21,860 for our follow up analyses. Additional information was collected from 
baseline questionnaires including self-reported age (categorized as < 65 years and ≥ 65 years), weight 
and  height  (converted  to  BMI,  kg/m2),  treatment  for  hypertension  (yes  or  no),  treatment  for 
hypercholesterolemia (yes or no), history of diabetes mellitus (yes or no), smoking status (categorized 
as current, former, or never), frequency of physical activity (categorized as none or exercise to a sweat 
at least one time per week), and family history of myocardial infarction (yes or no). 
We describe the frequency of cardiovascular risk factors and cholesterol awareness at baseline and 
follow-up.  We  also  report  the  frequency  of  physicians  who  were  aware  of  their  cholesterol  level 
among  groups  of  cardiovascular  risk  factors.  Unadjusted  logistic  regression  models  were  used  to 
describe the relationship between cardiovascular risk factors and awareness of cholesterol. Logistic 
regression models were also used to calculate the odds ratio (OR) and 95% confidence intervals (CI) of 
the  likelihood  of  physicians  who  reported  having  a  cardiovascular  risk  factor  on  the  baseline 
questionnaire and who also reported being unaware of their cholesterol level at follow up compared to 
physicians who reported not having a cardiovascular risk factor. Logistic models were also used to 
determine  if  physicians  who  smoked  throughout  the  study  were  also  more  likely  to  be  unaware 
throughout the study as compared to never smokers. 
 
3. Results 
 
At  the  baseline  64.1%  of  participants  were  unaware  of  their  cholesterol  level  whereas 
approximately 14 years later, 41.4% of participants were unaware of their cholesterol level (Table 1). 
During  this  period,  the  frequency  of  several  cardiovascular  risk  factors  including  hypertension, 
hyperlipidemia, diabetes mellitus, sedentary lifestyle, and obesity increased whereas the frequency of 
current  smokers  decreased.  Among  physicians  with  cardiovascular  risk  factors,  the  frequency  of 
cholesterol  unawareness  increased  in  every  group  (Table  2)  as  compared  to  physicians  without 
cardiovascular risk factors. The frequency of cholesterol unawareness among physicians who reported 
being current smokers was 71.7% at the baseline and 46.2% at the follow up. This represents a drop of 
35.6% in  the frequency of cholesterol  unawareness  among physicians  who reported being current 
smokers.  However, the  frequency of cholesterol  unawareness  among physicians  who smoked was 
higher than in any other category of cardiovascular risk factors at the baseline and remained higher 
than all categories of cardiovascular risk factors except physicians with diabetes at the follow up. 
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Table  1.  The  frequency  on  the  baseline  and  follow  up  questionnaire  of  cholesterol 
unawareness and cardiovascular risk factors. 
Variable  Baseline  Follow-up 
Cholesterol Unawareness, n (%)  14,154 (64.1)  9,138 (41.4) 
Age ≥ 65 years, n (%)  3,066 (13.9)  9,245 (54.8) 
Hypertension Treatment, n (%)  2,843 (13.5)  6,822 (40.5) 
Hyperlipidemia Treatment, n (%)  106 (0.57)  3,264 (19.6) 
Diabetes Mellitus, n (%)  533 (2.40)  1,719 (7.79) 
BMI ≥ 25 kg/m2, n (%)  9,591 (43.5)  9,779 (53.5) 
Sedentary Lifestyle, n (%)  6,056 (27.8)  8,585 (42.0) 
Family History of Myocardial 
Infarction, n (%) 
2,851 (13.1)  2,851 (13.1) 
Former Smoker, n (%)  8,671 (39.4)  8,253 (42.1) 
Current Smoker, n (%)  2,438 (11.1)  793 (4.05) 
 
Table 2. Frequency of physicians unaware of their cholesterol level at the baseline and 
follow up among groups of cardiovascular risk factors. 
Cardiovascular Risk Factor 
Unaware of Cholesterol Level 
Baseline  Follow up 
Age ≥ 65 years, %  58.1  26.0 
Hypertension Treatment, %  54.5  22.1 
Hyperlipidemia Treatment, %  36.8  6.7 
Diabetes Mellitus, %  52.9  48.3 
BMI ≥ 25 kg/m2, %  65.2  31.9 
Sedentary Lifestyle, %  68.0  43.9 
Family History of Myocardial 
Infarction, % 
62.7  36.5 
Former Smoker, %  64.6  36.2 
Current Smoker, %  71.7  46.2 
 
Compared to physicians without a particular cardiovascular risk factor, several groups of physicians 
with a particular cardiovascular risk factor were more likely to be unaware of their cholesterol level 
(Table 3). Compared to physicians that never smoked, physicians who were current smokers were 
more likely to be unaware of their cholesterol at the baseline (OR = 1.55, 95% CI = 1.40 to 1.70) and 
follow up (OR = 1.71, 95% CI = 1.48 to 1.97). The odds of cholesterol unawareness were higher 
among  physicians  that  currently  smoked  than  among  physicians  in  any  other  category  of 
cardiovascular risk at the baseline and follow up. The odds of cholesterol unawareness were lower 
among physicians that were currently being treated for hyperlipidemia than among physicians in any 
other category of cardiovascular risk at the baseline and follow-up. 
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Table 3. Odds of cholesterol unawareness among physicians with a cardiovascular risk 
factor compared to physicians without a cardiovascular risk factor. 
  Baseline  Follow up 
Cardiovascular Risk Factor  Cholesterol unawareness 
Odds ratio and 95% confidence interval 
Age ≥ 65 years  0.74 (0.69, 0.80)  1.40 (1.31, 1.51) 
Hypertension Treatment  0.63 (0.58, 0.69)  0.90 (0.83, 0.97) 
Hyperlipidemia Treatment,   0.34 (0.23, 0.50)  0.19 (0.16, 0.22) 
Diabetes Mellitus  0.62 (0.52, 0.74)  1.35 (1.23, 1.49) 
BMI ≥ 25 kg/m
2  1.08 (1.02, 1.14)  1.08 (1.01, 1.15) 
Sedentary Lifestyle  1.27 (1.19, 1.35)  1.63 (1.54, 1.72) 
Family History of Myocardial Infarction  0.93 (0.86, 1.01)  0.81 (0.74, 0.88) 
Former Smoker  1.12 (1.05, 1.18)  1.13 (1.06, 1.20) 
Current Smoker  1.55 (1.40, 1.70)  1.71 (1.48, 1.97) 
*Odds ratio based on physicians that had information on cholesterol awareness at either time point 
(follow up N=21,860) 
 
Thirty-five percent of the physicians who were unaware at baseline were now aware after 14 years 
of follow up and only 12% who were aware of their cholesterol at baseline were no longer aware upon 
follow up. Among the physicians who were always unaware (29%), they were more likely to have 
smoked throughout the study (OR 1.42, CI 1.211.67) as compared to never smokers (Table 4).  
 
Table 4. Odds of Being Unaware of Cholesterol at Baseline and Follow-up by Smoking History. 
  Unaware of Cholesterol  
at Baseline and follow-up 
  
Smoking History  OR  95% CI 
Follow-up  Questionnaire  Reported  Current 
Tobacco User  
1.71*  1.47  1.99 
Follow-up Questionnaire Reported Past Tobacco 
User  
1.16*  1.08  1.24 
Reported Current Tobacco User baseline and 
Follow-up  
1.42
†  1.21  1.67 
Abbreviations: OR = Odds Ratio; CI = Confidence Interval 
* referent group physicians that never smoked 
† referent group physicians that never smoked at both baseline and follow-up 
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4. Discussion 
 
In our study, the frequency of cholesterol unawareness among physicians who smoked was higher 
than among physicians with any other risk factor for cardiovascular disease at baseline and all but 
diabetes mellitus at follow up. The odds of cholesterol unawareness were highest among physicians 
who currently smoked than among physicians with any other risk factor of cardiovascular disease at 
baseline and follow up. The frequency of cholesterol unawareness in the overall cohort and among 
physicians who currently smoked declined between the baseline and follow up questionnaires. 
Our study suggests that although they are at high cardiovascular risk, physicians who smoke are less 
likely  to  adopt  a  prevention-oriented  lifestyle  than  are  physicians  with  other  cardiovascular  risk 
factors. Other studies have also reported that patients who smoke are less likely to adopt a prevention-
oriented  lifestyle  [7-11].  Although  these  physicians  likely  knew  about  the  increased  risk  for 
cardiovascular disease by smoking, the physicians who smoked did not appear to mitigate this risk by 
ascertaining their risk from cholesterol as frequently as physicians with other cardiovascular risks. It is 
very likely that the combination of these factors and not smoking alone accounts for the fact that 
individuals that smoke compared to non smokers have a reduced probability for a long life [12]. It is 
interesting to note that physicians who were being treated for hypertension and were therefore aware of 
a cardiovascular risk factor were less likely to be unaware of their cholesterol than were physicians not 
being treated for hypertension.  
Justification for the use of cholesterol unawareness as a surrogate for adoption of a prevention-
oriented lifestyle is based upon previously published findings [13,14]. We previously reported that 
physicians who were aware of their total cholesterol level were more likely to have a lower measured 
total cholesterol level and ratio of total cholesterol to high-density lipoprotein cholesterol level over 
time. 
Several limitations should be considered when  interpreting the findings of our study. Although 
physicians reported a cholesterol level, the level that they reported may not have been accurate. For 
our analysis, we were only interested in whether physicians were aware of their cholesterol level. We 
were not interested in how accurate they were in reporting their cholesterol level. It is possible that 
some physicians estimated their cholesterol level without actually having had their cholesterol level 
measured and were therefore misclassified as being aware when in fact they were truly unaware of 
their  cholesterol  level.  However,  this  is  unlikely  as  physicians  who  are  interested  in  having  their 
cholesterol measured have ample resources for having it measured. Because physicians are more likely 
to be aware of the increased cardiovascular risk associated with smoking and have more resources to 
measure  cholesterol,  our  findings  may  underestimate  the  true  association  between  smoking  and 
cholesterol unawareness in the general population. Finally, many changes likely occurred among the 
physicians after 14 years of follow up. Indeed, a large percentage of physicians that were not aware in 
1982 were now aware in 1997. We did not perform sub analyses on all the potential combinations of 
changing  awareness  and  changing  risk  factors.  Since  our  intent  was  to  focus  on  the  associations 
between  smoking  and  cholesterol  awareness,  we  did  evaluate  changes  in  awareness  among  this 
subgroup. Again our findings would suggest that physicians who were current smokers during the 14-
years of follow-up were also more likely to be unaware of their cholesterol throughout the study.  
 Int. J. Environ. Res. Public Health 2009, 6               
 
 
641 
5. Conclusions  
 
In  conclusion,  we  found  a  significant  positive  relationship  between  smoking  and  cholesterol 
unawareness.  Our  findings  suggest  that smokers  do not  appear to  adhere to  a prevention-oriented 
lifestyle.  
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